ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,799, issued on Sept. 16, was assigned to Zhejiang Yangli Pharmaceutical Technology Co. Ltd. (Zhejiang, China).
"Indazole-fused cyclic compound" was invented by Ke An (Shanghai), Na Gao (Shanghai), Guoping Hu (Shanghai), Jian Li (Shanghai), Shuhui Chen (Shanghai) and Deheng Sun (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "A novel indazole compound, a preparation method therefor, and use thereof in the preparation of drugs for treating related diseases. Specifically disclosed are a compound of formula (II) and a pharmaceutically acceptable salt thereof."
The patent was filed on June 28, 2021, under Application No. 18/002,476.
*For furth...